Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.

Nimol Khim (1) , Saorin Kim (1) , Christiane Bouchier (2) , Magali Tichit (2) , Frédéric Ariey (3) , Thierry Fandeur (4) , Pheaktra Chim (1) , Sopheakvatey Ke (1) , Sarorn Sum (1) , Somnang Man (1) , Arsène Ratsimbasoa (5) , Rémy Durand (6) , Didier Ménard (1)

1 Institut Pasteur du Cambodge
2 Génopole
3 Unité de Parasitologie Médicale
4 CERMES - Centre de Recherche Médicale et Sanitaire (Niamey, Niger)
5 Departement de Santé Publique
6 Laboratoire de Parasitologie-Mycologie

Molecular investigations performed following the emergence of sulfadoxine-pyrimethamine (SP) resistance in Plasmodium falciparum have allowed the identification of the dihydrofolate reductase (DHFR) enzyme as the target of pyrimethamine. Although clinical cases of Plasmodium malariae are not usually treated with antifolate therapy, incorrect diagnosis and the high frequency of undetected mixed infections has probably exposed non-P. falciparum parasites to antifolate therapy in many areas. In this context, we aimed to assess the worldwide genetic diversity of the P. malariae dhfr gene in 123 samples collected in Africa and Asia, areas with different histories of SP use. Among the 10 polymorphic sites found, we have observed 7 new mutations (K55E, S58R, S59A, F168S, N194S, D207G, and T221A), which led us to describe 6 new DHFR proteins. All isolates from African countries were classified as wild type, while new mutations and haplotypes were recognized as exclusive to Madagascar (except for the double mutations at nucleotides 341 and 342 [S114N] found in one Cambodian isolate). Among these nonsynonymous mutations, two were likely related to pyrimethamine resistance: S58R (corresponding to C59R in P. falciparum and S58R in Plasmodium vivax; observed in one Malagasy sample) and S114N (corresponding to S108N in P. falciparum and S117N in P. vivax; observed in three Cambodian samples).

Domaines: Maladies infectieuses

Nimol Khim, Saorin Kim, Christiane Bouchier, Magali Tichit, Frédéric Ariey, et al.. Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.. Antimicrobial Agents and Chemotherapy, 2012, 56 (2), pp.863-8. ⟨10.1128/AAC.05284-11⟩. ⟨pasteur-00741112⟩